From Reuters | Hospira Inc. said Monday that it will buy specialty drugmaker Javelin Pharmaceuticals Inc. for $145 million in cash. The deal will expand the medical suppliers’ pain management offerings.
Read the full story: Reuters.com
«
Back to home
This is the archives. For recent stories visit chicagobreakingbusiness.com »
